Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02912559
Title field or adapter rule
{'original_value': 'Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:28.916605+00:00
Published At
2026-04-14T00:00:00+00:00
Record Updated At
2026-10-28
Results Posted At
2026-04-14
Source Retrieved At
2026-10-31T22:18:26.854673+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Colon Adenocarcinoma", "DNA Repair Disorder", "Lynch Syndrome", "Stage III Colon Cancer AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-28", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT02912559"
protocolSection.identificationModule.officialTitle
"Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct
{"date": "2026-04-14", "type": "ACTUAL"}

Study condition terms

  • Colon Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • DNA Repair Disorder (protocolSection.conditionsModule.conditions)
  • Lynch Syndrome (protocolSection.conditionsModule.conditions)
  • Stage III Colon Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Arm I (combination chemotherapy, atezolizumab)'], 'description': 'Given IV', 'name': 'Atezolizumab', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (combination chemotherapy, atezolizumab)', 'Arm II (combination chemotherapy)'], 'description': 'Undergo blood sample collection', 'name': 'Biospecimen Collection', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (combination chemotherapy, atezolizumab)', 'Arm II (combination chemotherapy)'], 'description': 'Undergo CT', 'name': 'Computed Tomography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (combination chemotherapy, atezolizumab)', 'Arm II (combination chemotherapy)'], 'description': 'Given IV', 'name': 'Fluorouracil', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (combination chemotherapy, atezolizumab)', 'Arm II (combination chemotherapy)'], 'description': 'Given IV', 'name': 'Leucovorin Calcium', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (combination chemotherapy, atezolizumab)', 'Arm II (combination chemotherapy)'], 'description': 'Undergo MRI', 'name': 'Magnetic Resonance Imaging', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (combination chemotherapy, atezolizumab)', 'Arm II (combination chemotherapy)'], 'description': 'Given IV', 'name': 'Oxaliplatin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (combination chemotherapy, atezolizumab)', 'Arm II (combination chemotherapy)'], 'description': 'Ancillary studies', 'name': 'Quality-of-Life Assessment', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • Atezolizumab (protocolSection.armsInterventionsModule.interventions[].name)
  • Fluorouracil (protocolSection.armsInterventionsModule.interventions[].name)
  • Leucovorin Calcium (protocolSection.armsInterventionsModule.interventions[].name)
  • Oxaliplatin (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.